#CVRX CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026

#CVRX CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
#CVRX CVRx Appoints John Landry as Chief Financial Officer
Pomerantz Law Firm Investigates Possible Securities Fraud by CVRx, Inc. Affecting Investors #United_States #New_York #Pomerantz #investors #CVRx